Suppr超能文献

年龄和雄激素剥夺疗法对前列腺癌男性运动结果的影响。

Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer.

机构信息

Human and Environmental Physiology Research Unit, School of Human Kinetics, University of Ottawa, Ottawa, ON, K1N 6N5, Canada.

出版信息

Support Care Cancer. 2012 May;20(5):971-81. doi: 10.1007/s00520-011-1169-x. Epub 2011 May 3.

Abstract

PURPOSE

The purpose of this study is to examine the effects of age (≤ 65 years or >65 years) and androgen-deprivation therapy (ADT, presence or absence) as factors that may predict changes in body composition and fitness following a 24-week exercise program in prostate cancer patients.

METHODS

One hundred twenty-one men were randomly allocated to either: (1) aerobic exercise (AE), (2) resistance exercise (RE), or (3) usual care (UC). Body composition was assessed by DXA. Aerobic fitness was assessed through a maximal treadmill test. Muscular strength was assessed by leg extension and bench press using the eight-repetition maximum test. Responses were compared between younger (≤ 65 years) and older (> 65 years) patients with or without ADT.

RESULTS

There did not appear to be an interaction between age and ADT on body composition or fitness, nor were there any significant changes in body composition for participants ≤ 65 years. In participants aged >65 years, lean mass decreased in AE (p = 0.013) and UC (p = 0.006), but was preserved in RE. In participants receiving ADT, there was a decrease in lean mass in AE (p = 0.003) and UC (p < 0.001) but not in RE. The non-ADT group did not show any changes in body composition but did show improvements in muscular fitness following resistance training (p < 0.001).

CONCLUSION

Changes in body composition and physical fitness following a 24-week exercise program in men with prostate cancer are not influenced by age and/or ADT. Resistance training appears to attenuate the age-related decrease in lean mass and increase in body fat in older patients with prostate cancer and those receiving ADT.

摘要

目的

本研究旨在探讨年龄(≤65 岁或>65 岁)和雄激素剥夺治疗(ADT,存在或不存在)作为可能预测前列腺癌患者进行 24 周运动计划后身体成分和体能变化的因素。

方法

121 名男性被随机分配到以下三组之一:(1)有氧运动(AE),(2)抗阻运动(RE)或(3)常规护理(UC)。通过 DXA 评估身体成分。通过最大跑步机测试评估有氧健身。使用 8 次最大重复测试评估腿伸展和卧推来评估肌肉力量。在有或没有 ADT 的年轻(≤65 岁)和老年(>65 岁)患者之间比较反应。

结果

年龄和 ADT 之间似乎没有对身体成分或体能产生相互作用,≤65 岁的参与者的身体成分也没有任何显著变化。在年龄>65 岁的参与者中,AE(p=0.013)和 UC(p=0.006)中的瘦体重减少,但在 RE 中得到保留。在接受 ADT 的参与者中,AE(p=0.003)和 UC(p<0.001)中的瘦体重减少,但在 RE 中没有减少。非 ADT 组的身体成分没有任何变化,但在接受抗阻训练后肌肉健康状况有所改善(p<0.001)。

结论

在接受前列腺癌治疗的男性中,24 周运动计划后身体成分和体能的变化不受年龄和/或 ADT 的影响。抗阻训练似乎可以减轻老年前列腺癌患者和接受 ADT 治疗的患者与年龄相关的瘦体重减少和体脂肪增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验